1 form: solution. No registration in force in Georgia.
Controlled substance. For use only by a veterinarian, as the law prescribes.
Forms and doses0 of 1 in force in Georgia
The dose from the product's label, by species and weight. Check the label of the pack you use.
Form
Species
Dose
Frequency
Georgia
0.3 mg/ml, Solution · Cat
Cat
0.03–0.06 ml/kg
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; repeat only once after 1–2 hours. Long-term safety beyond five consecutive days is not established.
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; repeat only once after 1–2 hours. Long-term safety beyond five consecutive days is not established.
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; the same dose can potentiate sedation, requiring reduction of other centrally acting agents.
· repeat if necessary after 3–4 h at 10 microgram/kg or 5–6 h at 20 microgram/kg
repeat if necessary after 3–4 h at 10 microgram/kg or 5–6 h at 20 microgram/kg
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; the same dose can potentiate sedation, requiring reduction of other centrally acting agents.
· repeat if necessary after 3–4 h at 10 microgram/kg or 5–6 h at 20 microgram/kg
repeat if necessary after 3–4 h at 10 microgram/kg or 5–6 h at 20 microgram/kg
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
DogPerioperative/postoperative analgesia with exact Vetergesic Multidose 0.3 mg/ml
7.6/10
Good
CatPerioperative/postoperative analgesia with exact Vetergesic Multidose 0.3 mg/ml
Information not fully verifiedExact 10 ml multidose vial for IM or IV use. Dose in MICROGRAMS: 10–20 micrograms/kg equals 0.03–0.06 ml/kg. Dog repeat interval depends on dose; cats may receive only one repeat after 1–2 hours. Use an accurately graduated syringe and titrate subsequent analgesia to formal pain assessment.
Dose
Species
Weight
Route
Frequency
Source
0.03–0.06 ml/kg
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; repeat only once after 1–2 hours. Long-term safety beyond five consecutive days is not established.
Cat
Any weight
Intramuscular
if necessary, repeat once after 1–2 h
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Vetergesic Multidose 0.3 mg/ml solution for injection for dogs and cats - Summary of Product Characteristics
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; repeat only once after 1–2 hours. Long-term safety beyond five consecutive days is not established.
Cat
Any weight
Intravenous
if necessary, repeat once after 1–2 h
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Vetergesic Multidose 0.3 mg/ml solution for injection for dogs and cats - Summary of Product Characteristics
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; the same dose can potentiate sedation, requiring reduction of other centrally acting agents.
Dog
Any weight
Intramuscular
repeat if necessary after 3–4 h at 10 microgram/kg or 5–6 h at 20 microgram/kg
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Vetergesic Multidose 0.3 mg/ml solution for injection for dogs and cats - Summary of Product Characteristics
Exact Vetergesic Multidose dose: 10–20 microgram/kg = 0.03–0.06 ml/kg IM or IV for postoperative analgesia; the same dose can potentiate sedation, requiring reduction of other centrally acting agents.
Dog
Any weight
Intravenous
repeat if necessary after 3–4 h at 10 microgram/kg or 5–6 h at 20 microgram/kg
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Vetergesic Multidose 0.3 mg/ml solution for injection for dogs and cats - Summary of Product Characteristics
Known hypersensitivity to buprenorphine or any excipient is a contraindication.
Warning
Do not use buprenorphine before caesarean section because it can cause respiratory depression in the offspring around birth. Use cautiously during pregnancy and, if needed after surgery, monitor the dam and neonates closely.
Warning
Buprenorphine is not recommended during lactation because concentrations in milk can equal or exceed plasma concentrations.
Warning
Buprenorphine can cause respiratory depression. Use cautiously in animals with impaired respiratory function or in those receiving other drugs that depress respiration.
Warning
Use buprenorphine cautiously in hepatic impairment, especially biliary-tract disease, because hepatic metabolism affects the intensity and duration of its action.
Warning
Buprenorphine carries greater risk in renal, cardiac, or hepatic dysfunction and in shock. Use only after a careful benefit-risk assessment with appropriate monitoring.
Warning
Use buprenorphine cautiously in cardiac dysfunction or shock because cardiovascular adverse effects, including bradycardia and occasionally hypertension or tachycardia, may occur.
Caution
Do not administer buprenorphine intrathecally or epidurally. Opioid antagonists may not fully reverse its effects; naloxone can help with respiratory depression but repeated dosing or infusion may be required because buprenorphine is long acting.
Caution
Safety of buprenorphine has not been established in animals younger than 7 weeks.
Do not combine buprenorphine with morphine or other opioid analgesics, including fentanyl, pethidine, methadone, or butorphanol, because their analgesic effects may be unpredictable or antagonistic.
Recommendation: Do not administer concurrently; buprenorphine may antagonize a mu-opioid agonist.
Centrally acting drugs, including tranquillisers, sedatives, and hypnotics, can increase buprenorphine-induced drowsiness. Combined use with sedatives can also increase depression of heart rate and respiration.
Recommendation: Reduce the sedative dose during premedication; monitor heart rate and respiration.
Centrally acting drugs, including tranquillisers, sedatives, and hypnotics, can increase buprenorphine-induced drowsiness. Combined use with sedatives can also increase depression of heart rate and respiration.
Recommendation: Reduce the sedative dose during premedication; monitor heart rate and respiration.
Related products
Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.
Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.
For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.
Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.
The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.
